XML 18 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Management's Plans for Continuing Operations (Details Textuals) (USD $)
3 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Management's Plans for Continuing Operations    
Net loss $ (1,424,072) $ (4,431,853)
Operating loss (1,416,485) (4,424,788)
Share based compensation expense 351,590  
Operating loss from BluScience 192,399  
Additional proceeds expected in 2013 from sale of BluScience 1,333,334  
Warrants outstanding 4,389,281  
Exercise price $ 0.21  
Additional proceeds expected from warrant exercise $ 921,749